ADMA Biologics ADMA Deposits And Other Noncurrent Assets
Deposits And Other Noncurrent Assets at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept adma:DepositsAndOtherNoncurrentAssets.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's deposits and other noncurrent assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's deposits and other noncurrent assets?
- ADMA Biologics (ADMA) reported deposits and other noncurrent assets of $8.47M in Q1 2026.
- How has ADMA Biologics's deposits and other noncurrent assets changed year-over-year?
- ADMA Biologics's deposits and other noncurrent assets increased by 3.4% year-over-year, from $8.19M to $8.47M.
- What is the long-term trend for ADMA Biologics's deposits and other noncurrent assets?
- Over 5 years (2020 to 2025), ADMA Biologics's deposits and other noncurrent assets has grown at a 32.5% compound annual growth rate (CAGR), from $2.11M to $8.6M.
- What does deposits and other noncurrent assets mean?
- This represents long-term assets, such as security deposits or restricted cash, that are not expected to be converted into cash within one year. These assets reflect capital tied up in long-term operational commitments or contractual obligations. Monitoring these helps assess the company's liquidity position regarding non-liquid, long-term resource allocations.